Clinical Trials

366 enrolled

Breast Neoplasms

NCT05912062 2023-09-29

BiOnHER

Unknown

80 enrolled

Breast Neoplasms, Neoplasms

NCT05966441 2023-07-28

Role of Curcumin in Paclitaxel Induced PN

80 enrolled

Breast Neoplasms

NCT05749575 2023-03-01

Chidamide Plus PD-1 Plus Paclitaxel of Neoadjuvant Treatment in Low HR Expression,HER2-negative Early Breast Cancer.

28 enrolled

Breast Neoplasms

NCT05681728 2023-01-12

A Phase II Study Evaluating the Efficacy and Safety of Pembrolizumab in Combination With Chemotherapy as Neoadjuvant Therapy for Triple-negative Breast Cancer

26 enrolled

Breast Neoplasms

NCT05580887 2022-10-14

Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients

Unknown

35 enrolled

BreastGastrointestinal

Breast Neoplasms, Pancreatic Neoplasms

NCT01547741 2022-04-14

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

1,871 enrolled

Breast Neoplasms

NCT04946227 2021-06-30

Pembrolizumab and Paclitaxel in Hormone Receptor-positive, hyperMUTATted Metastatic Breast Cancer Identified by Whole exOme sequeNcing ('MUTATION2')

52 enrolled

Breast Neoplasms

NCT04559308 2020-09-22

The Effect of Metformin on Breast Cancer Patients

80 enrolled

Breast Neoplasms

NCT04499118 2020-08-05

AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer

Breast Neoplasms

NCT03048942 2019-11-13

CONCEPT

160 enrolled

Breast Neoplasms

NCT03949634 2019-05-14

Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD)

272 enrolled

Breast Neoplasms

NCT00499525 2019-05-03

Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer

180 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT03756090 2018-12-07

PECP

Phase NA Unknown

Breast Diseases, Breast Neoplasms

NCT03735082 2018-11-08

Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer

29 enrolled

Breast Neoplasms

NCT03429972 2018-03-14

Regional Cryotherapy in Preventing Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients

51 enrolled

Breast Neoplasms

NCT02694224 2017-10-24

SHH-CM

40 enrolled

Breast Neoplasms

NCT03273595 2017-09-06

Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive Breast Cancer

Breast Neoplasms

NCT02396108 2017-02-03

Dose-confirmation Study of ASLAN001 Combined With Weekly Paclitaxel and Carboplatin in Advanced Solid Tumours, Followed by a Study in Patients With Stage I-III HER2 Positive Breast Cancer

55 enrolled

Breast Neoplasms

NCT00499603 2016-11-01

Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer

62 enrolled 13 charts

Breast Neoplasms

NCT02207361 2015-12-22

Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer

Phase 4 Unknown

120 enrolled

Breast Neoplasms

NCT02230319 2015-10-01

Prevention of Paclitaxel Neuropathy With Cryotherapy

39 enrolled

Breast Neoplasms, Peripheral Nervous System Diseases

NCT01764087 2015-05-18

A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors

60 enrolled

BreastGastrointestinal

Breast Neoplasms, Carcinoma, Neoplasms, Stomach Neoplasms

NCT02041338 2014-11-25

Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer

200 enrolled

Breast Neoplasms

NCT02059876 2014-02-12

Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast Cancer

60 enrolled

Pathologic Complete Response, Breast Neoplasms

NCT00002627 2014-01-10

Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer

30 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00002628 2014-01-10

Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer

50 enrolled

Breast Neoplasms

NCT00003253 2013-12-19

Evaluation of Drug Resistance in Patients With Metastatic Breast Cancer

Breast Neoplasms, Breast Neoplasms, Male

NCT00005581 2013-12-18

Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer

1,000 enrolled

Breast Neoplasms

NCT00533936 2013-08-26

Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer

160 enrolled

Breast Neoplasms

NCT00070278 2013-08-07

Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer

800 enrolled

Breast Neoplasms

NCT00629278 2013-08-07

Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer

2,500 enrolled

Breast Neoplasms

NCT01848197 2013-05-07

PATEN

Phase NA Unknown

1,000 enrolled

Breast Neoplasms

NCT01428414 2012-08-23

Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer

Breast Neoplasms

NCT01378533 2011-12-28

The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00538395 2011-12-13

Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast Cancer

Phase NA Unknown

Breast Neoplasms

NCT00154882 2010-01-21

Paclitaxel (Phyxol) and Cisplatin as First-line Chemotherapy for Metastatic Breast Cancer

43 enrolled

Breast Neoplasms

NCT00518583 2010-01-15

Phase II Study in Patients With Operable Breast Cancer

30 enrolled

Breast Neoplasms

NCT00006120 2008-07-24

Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer

Breast Neoplasms

NCT00289263 2006-02-09

Maintenance Chemotherapy in Metastatic Breast Cancer

524 enrolled